Skip to content

STRONG Program for Cancer Patients

STRONG-PD: Support Through Remote Observation And Nutrition Guidance (STRONG) Program For Cancer Patients With Peritoneal Disease

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05649969
Enrollment
10
Registered
2022-12-14
Start date
2022-12-01
Completion date
2025-01-21
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Cancer

Brief summary

The purpose of the study is to assess the feasibility and participant satisfaction with the Support through Remote Observation and Nutrition Guidance (STRONG) program. The program provides nutrition support for participants living with gastrointestinal cancer who are receiving chemotherapy and surgical treatment.

Interventions

Participants will have an initial consultation with a dietician and then biweekly follow-up visits (in person or virtually) for 12 weeks.

Participants will keep a daily diary of food intake with a Fitbit smartphone application and wear a Fitbit for 12 weeks

BEHAVIORALQuestionnaires

Participants will complete a questionnaire electronically at baseline and again at week 4, 8, 12 and 16.

Sponsors

H. Lee Moffitt Cancer Center and Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Gastrointestinal Cancer diagnosis (e.g., colon cancer, appendiceal cancer) * Peritoneal disease diagnosis * Received Cytoreductive Surgery and Heated Intra-Peritoneal Chemotherapy (CRS-HIPEC) for curative intent at Moffitt * Transitioned to an oral diet post-surgery * Able to speak and read English * Able to provide informed consent

Exclusion criteria

* Documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., psychosis, active substance abuse) * Undergoing concurrent treatment for a secondary primary cancer * Receipt of parenteral or enteral nutrition after surgery

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of the STRONG Programat 12 weeksFeasibility of the Support through Remote Observation and Nutrition Guidance (STRONG) program will be assessed using recruitment and retention rates, along with data completion rates.
Acceptability of the STRONG Programat 16 weeksThe Acceptability of the STRONG Program measure uses 4 items to indicate participant satisfaction. The measure uses a scale of 0-5, 0 meaning the participant completely disagrees with the statements regarding intervention satisfaction and 5 indicating complete agreement with the statements regarding intervention satisfaction. The measure score ranges from 0-20 with 20 indicating the highest degree of satisfaction.
Adherence to the STRONG Programat 16 weeksParticipant adherence to the Support through Remote Observation and Nutrition Guidance (STRONG) program will be assessed by Fitbit dietary log data and dietician care visit data.
Efficacy of STRONG Program on Treatment Outcomesat 16 weeksEfficacy of STRONG program on treatment outcomes will be measured by reviewing the Electronic Health Record for hospital readmissions and cause of readmission

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAmir Alishahi Tabriz, MD, PhD, MPH

Moffitt Cancer Center

PRINCIPAL_INVESTIGATORBen Powers, MD

Moffitt Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026